Key Takeaways
- • Dan Loeb's Third Point hedge fund is bankrolling a multi-jurisdictional patent litigation campaign against Intel, Amazon Web Services, and Fujitsu through its 75% majority stake in chip design company R2 Semiconductor, funding both legal costs and a €79 million escrow requirement in German court proceedings.
- • R2 Semiconductor has secured preliminary court victories in Germany, with a regional court issuing injunctions in February 2024 against the sale of certain Intel chip lines, and a higher court rejecting Intel's appeal on March 8, 2024—setting the stage for a British patent trial beginning in April 2024.
- • The patent dispute centers on voltage regulation technology in semiconductors; while Intel contends the patent applies only to older chip generations, R2 and Third Point assert it covers Intel's current-generation products, with potential implications for Intel's European sales across multiple chip lines.
- • Third Point's 15-year investment history in R2 (initial investment made approximately 2009) demonstrates a long-term capital deployment strategy combining equity ownership with litigation financing to extract value from intellectual property disputes.
- • The litigation simultaneously targets Intel's major customers (Hewlett Packard Enterprise and Dell, with Intel indemnifying both) as well as cloud infrastructure providers, signaling a broad-based patent enforcement strategy across the semiconductor supply chain.
Summary
R2 Semiconductor has already achieved material court victories in European jurisdictions. In February 2024, a regional court in Germany issued injunctions against the sale of at least certain Intel chip lines, and when Intel appealed the decision, a higher court rejected the challenge on March 8, 2024. A separate patent trial in Britain is scheduled to commence in April 2024. The original German suit named Intel alongside two of its major customers, Hewlett Packard Enterprise and Dell, with Intel providing indemnification to both defendants. The financial commitment from Third Point is substantial: the firm is covering R2's litigation expenses while also posting €79 million in escrow to satisfy German court requirements as the proceedings continue.
The technical crux of the dispute involves patent claims related to voltage regulation mechanisms in semiconductor design. Intel has positioned its defense around the argument that the R2 patent pertains only to older generations of its chip architectures. However, R2 and Third Point have indicated to The New York Times that the patent's scope may extend to Intel's current-generation products, a position that would materially expand the potential financial and operational impact on Intel's business across Europe. Third Point's decision to finance this litigation underscores the firm's view that the patent claims possess significant monetizable value and enforceability. The hedge fund first invested in R2 approximately 15 years prior to this 2024 action, accumulating its controlling stake through successive investments, demonstrating a long-term strategy of combining equity ownership with aggressive intellectual property monetization.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.